ANTITUMOR ACTIVITY OF C-MYC INHIBITOR KSI-3716 IN A GEMCITABINE-RESISTANT BLADDER CANCER

被引：1
|
作者：
Seo, Ho Kyung
Kwon, Whi-An
Sohn, Dong Wan
Son, Jeong Hwan
Park, Weon Seo
Lee, Kang-Hyun
Lee, Sang-Jin
Jeong, Kyung-Chae
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.843
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP21-15
引用
收藏
页码：E231 / E231
页数：1
相关论文
共 50 条
  • [31] c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
    Nebbioso, Angela
    Carafa, Vincenzo
    Conte, Mariarosaria
    Tambaro, Francesco Paolo
    Abbondanza, Ciro
    Martens, Joost
    Nees, Matthias
    Benedetti, Rosaria
    Pallavicini, Isabella
    Minucci, Saverio
    Garcia-Manero, Guillermo
    Iovino, Francesco
    Lania, Gabriella
    Ingenito, Concetta
    Petrizzi, Valeria Belsito
    Stunnenberg, Hendrik G.
    Altucci, Lucia
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2542 - 2555
  • [32] Comparison of c-Myc inhibitor effectiveness in various cancer cell lines
    Kuna, Marija
    Raucher, Drazen
    CANCER RESEARCH, 2015, 75
  • [33] Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms
    Ferro, Matteo
    Giubert, Gaia
    Zappavigna, Silvia
    Perdona, Sisto
    Facchini, Gaetano
    Sperlongano, Pasquale
    Porto, Stefania
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    Abbruzzese, Alberto
    Altieri, Vincenzo
    Caraglia, Michele
    ONCOLOGY REPORTS, 2012, 27 (02) : 409 - 415
  • [34] DETECTION OF THE C-MYC GENE-PRODUCT IN URINARY-BLADDER CANCER
    KOTAKE, T
    SAIKI, S
    KINOUCHI, T
    SHIKU, H
    NAKAYAMA, E
    JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (12): : 1198 - 1201
  • [35] A triterpenoid derivative has strong antitumor activities in gemcitabine-resistant advanced bladder cancer models and promotes immune cell infiltration in a high grade murine syngeneic model
    Seremak, Juliette Rose
    Gupta, Kunj Bihari
    Panda, Siva S.
    Lokeshwar, Bal L.
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells
    Lee, Jee-Hyung
    Choi, Jin Ho
    Lee, Kyung-Min
    Lee, Min Woo
    Ku, Ja-Lok
    Oh, Dong-Chan
    Shin, Yern-Hyerk
    Kim, Dae Hyun
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong -Tae
    Lee, Sang Hyub
    Lee, Sang Kook
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (01) : 123 - 135
  • [37] c-MYC is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Vivas-Mejia, Pablo E.
    Reyes, Jeyshka
    Sood, Anil K.
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [38] A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells
    Ahmed Abdullah Ahmed
    Chiara Marchetti
    Stephan A. Ohnmacht
    Stephen Neidle
    Scientific Reports, 10
  • [39] Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine
    Bressin, Celine
    Bourgarel-Rey, Veronique
    Carre, Manon
    Pourroy, Bertrand
    Arango, Diego
    Braguer, Diane
    Barra, Yves
    ANTI-CANCER DRUGS, 2006, 17 (02) : 181 - 187
  • [40] Expression of Fas/FasL and c-myc in bladder cancer and their correlation with tumor immune function
    Li, Jian
    Zhou, Yibin
    Li, Qingwen
    Zhang, Jiajun
    Sun, Wenyan
    Dai, Changyuan
    Shan, Yuxi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (06): : 6357 - 6363
12345